Abstract 179: Accessing the Swine Middle Meningeal Artery to Evaluate a Novel Embolic Agent IMPASS
Middle meningeal artery (MMA) embolization has emerged as a promising stand‐alone or adjunct treatment for patients with chronic subdural hematomas (cSDH). Improved penetration of the MMA is believed to improve the efficacy of the embolization procedure and its long‐term clinical success. The goal of this feasibility study is to evaluate the performance of a novel liquid embolic (IMPASS, Fluidx Medical Technology) compared with a control (Onyx 18, Medtronic) in a swine MMA embolization model.
Authors
- Donald Pionessa
- Debbie Smith (ORCID: https://orcid.org/0000-0001-7875-1582)
- Maxim Mokin (ORCID: https://orcid.org/0000-0003-4270-8667)
- S Setlur Nagesh
- Carmon Koenigsknecht
- M Bainsmith
- Laura Gutiérrez (ORCID: https://orcid.org/0000-0003-1872-7163)
- Adnan Siddiqui
Institutions
- University of South Florida (US)
- Rex Medical (United States) (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- Stroke Vascular and Interventional Neurology
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1161/svin.04.suppl_1.179
- Primary Topic
- Cerebral Venous Sinus Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00